✦ LIBER ✦

PND21 COST-UTILITY OF PRAMIPEXOL COMPARED WITH L-DOPA/CARBIDOPA INTHE TREATMENT OF PARKINSON'S DISEASE IN MEXICO

✍ Scribed by J Idrovo; R Rivas; L Zapata

Book ID: 118609148
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 69 KB
Volume: 11
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)70454-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative study of selegiline plus L-d

Comparative study of selegiline plus L-dopa–carbidopa versus L-dopa–carbidopa alone in the treatment of parkinson's disease

✍ Timothy Brannan; Dr. Melvin D. Yahr 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 383 KB 👁 1 views

The long-term effect of selegiline (L-deprenyl) in the treatment of Parkinson's disease has not been clearly delineated. We report on a group of patients whose treatment was initiated with selegiline (n = 43) and then subsequently included L-dopa-carbidopa (Sinemet) and in whom an extended period o

PND21 COST-EFFECTIVENESS OF RASAGILINE C

PND21 COST-EFFECTIVENESS OF RASAGILINE COMPARED TO OTHER FIRST LINE TREATMENT OPTIONS OF EARLY PARKINSON'S DISEASE IN THE UNITED STATES

✍ R Farkouh; MR Wilson; ML Tarrants; J Castelli-Haley; C Armand 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PND27 COST UTILITY ANALYSIS OF ORPHAN DR

PND27 COST UTILITY ANALYSIS OF ORPHAN DRUGS: CASE STUDY OF DUODENAL LEVODOPA INFUSION VERSUS STANDARD TREATMENT IN PATIENTS WITH ADVANCED PARKINSON'S DISEASE IN SWEDEN

✍ M Willis; B Gradl 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB